Hematopoietic Stem Cell Transplantation Outcomes for 11 Patients with Dedicator of Cytokinesis 8 (DOCK8) Deficiency

BACKGROUND: Dedicator of cytokinesis 8 (DOCK8) deficiency can be cured by allogeneic hematopoietic stem cell transplantation (HSCT). Reports of outcome are still limited. OBJECTIVE: To analyze the results of HSCT in patients with DOCK8 deficiency and report whether approaches resulting in mixed chim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Allergy Clin Immunol
Autori principali: Al-Herz, Waleed, Chu, Julia I., van der Spek, Jet, Raghupathy, Raj, Massaad, Michel J., Keles, Sevgi, Biggs, Catherine M., Cockerton, Lucinda, Chou, Janet, Dbaibo, Ghassan, Elisofon, Scott A., Hanna-Wakim, Rima, Kim, Heung Bae, Lehmann, Leslie E., McDonald, Douglas R., Notarangelo, Luigi D., Veys, Paul, Chatila, Talal, Geha, Raif S., Gaspar, H. Bobby, Pai, Sung-Yun
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354354/
https://ncbi.nlm.nih.gov/pubmed/27130861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.02.022
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi